Knowledge Center
White Paper / May 08, 2026
Integrated Nasal Powder Development Platform
Source:
Hovione White Paper
Why are nasal powders finally having their moment?
Nasal powder drug products are moving from niche to necessity. The intranasal route uniquely combines patient convenience, fast onset, and access to therapeutic spaces that are otherwise diffcult to reach, particularly the brain via olfactory and trigeminal pathways.
Related links
Also in the Knowledge Center
/ Jan 24, 2019
Preparation of amorphous form of vilanterol trifenatate for the treatment of asthma and chronic obstructive pulmonary disease
Read more
Scientific Article
Scientific Article
Scientific Article